# Exploring immobilization strategies of antimicrobial peptides onto MAO-treated titanium to fight MRSA colonization and preserve osteogenic activity

**Authors:** Natália A. Costa, Cláudia Monteiro, Liliana Grenho, Ana R. Ribeiro, Victoria Leiro, Maria H. Fernandes, Paulo N. Lisboa-Filho, M. Cristina L. Martins

PMC · DOI: 10.1016/j.mtbio.2026.102896 · 2026-02-09

## TL;DR

This study explores ways to attach antimicrobial peptides to titanium surfaces to fight MRSA infections while supporting bone growth.

## Contribution

A combined strategy of PEG grafting and AMP adsorption effectively kills MRSA and supports osteogenic activity.

## Key findings

- MSI-78 immobilization via physical adsorption or covalent grafting killed MRSA within 5 hours.
- PEGylated surfaces with adsorbed AMP reduced MRSA colonization and killed 80% of adherent bacteria.
- PEGylated MAO surfaces maintained cytocompatibility and promoted osteogenic response.

## Abstract

Alternative therapies to systemic antibiotics are increasingly explored to prevent infections associated with bone implants. Among them, the surface functionalization of titanium with antimicrobial peptides (AMP) is particularly promising due to their broad-spectrum activity and low risk of inducing bacterial resistance. However, a critical challenge remains in achieving both effective antibacterial action and the promotion of osseointegration. This proof-of-concept study investigates different strategies for immobilizing AMP onto bioactive micro-arc oxidation (MAO) coatings on titanium, aiming to combat methicillin-resistant Staphylococcus aureus (MRSA) colonization while preserving the osseointegration potential of MAO surfaces. The peptide MSI-78 was immobilized either by physical adsorption or covalent grafting, using 1,1′-carbonyldiimidazole (CDI) coupling agent or poly(ethylene glycol) (PEG) spacer. All immobilization strategies preserved the heterogeneous porous architecture and calcium/phosphorus doping of the complex MAO coatings. Prior to bacterial incubation, the surfaces were pre-conditioned with human plasma proteins. MSI-78, whether by physical adsorption or covalent grafting, killed MRSA after 5 h, but also promoted bacterial adhesion to the surface. In contrast, the combined strategy of grafted PEG and physically adsorbed AMP promoted a remarkable antibacterial effect, by reducing MRSA colonization and killing about 80% of adherent bacteria. Regardless of the immobilization strategy, bacterial killing appeared to occur via contact-mediated membrane disruption. Moreover, these PEGylated MAO surfaces with adsorbed AMP maintained excellent cytocompatibility with bone-like cells and supported osteogenic response, underscoring their potential as bioactive coatings for titanium implants.

Image 1

•Antimicrobial peptides (AMP) were successfully immobilized onto MAO TiO2 surfaces.•AMP immobilization occurred via physical adsorption or covalent grafting.•CDI coupling or PEG spacer were used to modulate conjugation.•AMP immobilization provided surface bactericidal activity against MRSA.•Grafted PEG + adsorbed AMP enhance antibacterial action and support osseointegration.

Antimicrobial peptides (AMP) were successfully immobilized onto MAO TiO2 surfaces.

AMP immobilization occurred via physical adsorption or covalent grafting.

CDI coupling or PEG spacer were used to modulate conjugation.

AMP immobilization provided surface bactericidal activity against MRSA.

Grafted PEG + adsorbed AMP enhance antibacterial action and support osseointegration.

## Linked entities

- **Chemicals:** MSI-78 (PubChem CID 16137672), 1,1′-carbonyldiimidazole (PubChem CID 68263), poly(ethylene glycol) (PubChem CID 9033)
- **Diseases:** MRSA (MONDO:0100073)

## Full-text entities

- **Genes:** ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, MAL (mal, T cell differentiation protein (MAL blood group)) [NCBI Gene 4118] {aka HLD28, MVP17, VIP17}, CAMP (cathelicidin antimicrobial peptide) [NCBI Gene 820] {aka CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** CDI (MESH:C538557), MRSA (MESH:D013203), bacterial (MESH:D001424), infected (MESH:D007239), cytotoxic (MESH:D064420)
- **Chemicals:** alpha-MEM (MESH:C420642), polydopamine (MESH:C568283), calcium phosphate (MESH:C020243), ascorbic acid (MESH:D001205), 2-propanol (MESH:D019840), acetic acid (MESH:D019342), EtOH (MESH:D000431), methicillin (MESH:D008712), glycine (MESH:D005998), imidazole (MESH:C029899), palladium (MESH:D010165), water (MESH:D014867), phospholipid (MESH:D010743), leucine (MESH:D007930), valine (MESH:D014633), F (MESH:D005461), 1,1'-Carbonyldiimidazole (MESH:C006900), Peptide (MESH:D010455), isoleucine (MESH:D007532), N (MESH:D009584), dichloromethane (MESH:D008752), PEG (MESH:D011092), POPC (MESH:C065191), Triton X-100 (MESH:D017830), 6-amino-hexanoic acid (MESH:D015119), hexamethyldisilazane (MESH:C024548), polymer (MESH:D011108), alanine (MESH:D000409), streptomycin (MESH:D013307), C (MESH:D002244), borax (MESH:C018851), calcium carbonate (MESH:D002119), gold (MESH:D006046), NaCl (MESH:D012965), COO (MESH:C041069), P (MESH:D010758), AMP (MESH:D000089882), phosphate (MESH:D010710), chitosan (MESH:D048271), calcium phosphates (MESH:D002130), acids (MESH:D000143), O (MESH:D010100), PBS (MESH:D007854), lysine (MESH:D008239), glutaraldehyde (MESH:D005976), p-nitrophenyl phosphate (MESH:C008644), HNO3 (MESH:D017942), argon (MESH:D001128), Ca (MESH:D002118), resazurin (MESH:C005843), maleimide (MESH:C043592), SiC (MESH:C022088), TiO2 (MESH:C009495), CO2 (MESH:D002245), PFA (MESH:C003043), Cys (MESH:D003545), calcein (MESH:C007740), THF (MESH:C018674), amphotericin B (MESH:D000666), thiol (MESH:D013438)
- **Species:** Xenopus laevis (African clawed frog, species) [taxon 8355], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** N5772A
- **Cell lines:** MG-63 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0426), CRL-1427 — Sigmodon hispidus (Hispid cotton rat), Spontaneously immortalized cell line (CVCL_YD58), MSI-78 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_SZ05)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924753/full.md

---
Source: https://tomesphere.com/paper/PMC12924753